Lo S - Search Results

1

The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors.

Lai-Kwon J, Khoo C, Lo S, Milne D, Mohamed M, Raleigh J, Smith K, Lisy K, Sandhu S, Jefford M. Lai-Kwon J, et al. Among authors: lo s. J Cancer Surviv. 2019 Aug;13(4):503-511. doi: 10.1007/s11764-019-00770-0. Epub 2019 Jun 4. J Cancer Surviv. 2019. PMID: 31165342

2

Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.

Menzies AM, Wilmott JS, Drummond M, Lo S, Lyle M, Chan MM, Thompson JF, Guminski A, Carlino MS, Scolyer RA, Kefford RF, Long GV. Menzies AM, et al. Among authors: lo s. Cancer. 2015 Nov 1;121(21):3826-35. doi: 10.1002/cncr.29586. Epub 2015 Jul 28. Cancer. 2015. PMID: 26218930 Free article.

3

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.

Parakh S, Park JJ, Mendis S, Rai R, Xu W, Lo S, Drummond M, Rowe C, Wong A, McArthur G, Haydon A, Andrews MC, Cebon J, Guminski A, Kefford RF, Long GV, Menzies AM, Klein O, Carlino MS. Parakh S, et al. Among authors: lo s. Br J Cancer. 2017 Jun 6;116(12):1558-1563. doi: 10.1038/bjc.2017.142. Epub 2017 May 18. Br J Cancer. 2017. PMID: 28524161 Free PMC article.

4

Reply to M. Horiguchi et al.

Lo SN, Sandhu S. Lo SN, et al. J Clin Oncol. 2018 Mar 1;36(7):722-723. doi: 10.1200/JCO.2017.76.5347. Epub 2018 Jan 16. J Clin Oncol. 2018. PMID: 29337635 No abstract available.

5

Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies.

Lee JH, Long GV, Menzies AM, Lo S, Guminski A, Whitbourne K, Peranec M, Scolyer R, Kefford RF, Rizos H, Carlino MS. Lee JH, et al. Among authors: lo s. JAMA Oncol. 2018 May 1;4(5):717-721. doi: 10.1001/jamaoncol.2017.5332. JAMA Oncol. 2018. PMID: 29423503 Free PMC article.

6

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.

Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, Wilmott JS, Edwards J, Gonzalez M, Scolyer RA, Menzies AM, McArthur GA. Long GV, et al. Among authors: lo s. Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27. Lancet Oncol. 2018. PMID: 29602646 Clinical Trial.

7

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.

Mitchell EL, Lau PKH, Khoo C, Liew D, Leung J, Liu B, Rischin A, Frauman AG, Kee D, Smith K, Brady B, Rischin D, Gibson A, Mileshkin L, Klein O, Weickhardt A, Arulananda S, Shackleton M, McArthur G, Östör A, Cebon J, Solomon B, Buchanan RR, Wicks IP, Lo S, Hicks RJ, Sandhu S. Mitchell EL, et al. Among authors: lo s. Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13. Eur J Cancer. 2018. PMID: 30439628

8

Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy.

Pires da Silva I, Lo S, Quek C, Gonzalez M, Carlino MS, Long GV, Menzies AM. Pires da Silva I, et al. Among authors: lo s. Cancer. 2020 Jan 1;126(1):86-97. doi: 10.1002/cncr.32522. Epub 2019 Oct 4. Cancer. 2020. PMID: 31584722 Free article. Clinical Trial.

9

Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma.

Mason R, Dearden HC, Nguyen B, Soon JA, Smith JL, Randhawa M, Mant A, Warburton L, Lo S, Meniawy T, Guminski A, Parente P, Ali S, Haydon A, Long GV, Carlino MS, Millward M, Atkinson VG, Menzies AM. Mason R, et al. Among authors: lo s. Pigment Cell Melanoma Res. 2020 Mar;33(2):358-365. doi: 10.1111/pcmr.12831. Epub 2019 Nov 2. Pigment Cell Melanoma Res. 2020. PMID: 31587511

10

Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system.

Kashani-Sabet M, Miller JR 3rd, Lo S, Nosrati M, Stretch JR, Shannon KF, Spillane AJ, Saw RPM, Cleaver JE, Kim KB, Leong SP, Thompson JF, Scolyer RA. Kashani-Sabet M, et al. Among authors: lo s. Cancer. 2020 Nov 1;126(21):4717-4725. doi: 10.1002/cncr.33088. Epub 2020 Aug 11. Cancer. 2020. PMID: 32780467 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,855 results

Search Page

Filters